Errata

The December 10, 2017, article by Dreyling et al, entitled “Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma” (J Clin Oncol 10.1200/JCO.2017.75.4648), was published with an error.

The TOC category was listed as Prostate Cancer. It should have been Hematologic Malignancy.

This has been corrected as of January 12, 2018. Journal of Clinical Oncology apologizes for the error.